STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported a fourth-quarter loss of $2.2 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Stoughton, Massachusetts-based company said it had a loss of 7 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The specialty pharmaceutical company posted revenue of $74.2 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $73.3 million.
For the year, the company reported that its loss narrowed to $22.7 million, or 68 cents per share. Revenue was reported as $296.7 million.
Collegium Pharmaceutical shares have risen slightly more than 5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $21.68, an increase of 50% in the last 12 months.